140 related articles for article (PubMed ID: 36222113)
1. Impact of
Wang D; Yong L; Zhang Q; Chen H
Pharmacogenomics; 2022 Nov; 23(16):903-911. PubMed ID: 36222113
[No Abstract] [Full Text] [Related]
2. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
[TBL] [Abstract][Full Text] [Related]
3. Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation.
Zhang H; Ma K; Liu W; Yang F; Liu J; Zhou H
Gene; 2016 Oct; 591(1):80-84. PubMed ID: 27356304
[TBL] [Abstract][Full Text] [Related]
4. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.
Scordo MG; Pengo V; Spina E; Dahl ML; Gusella M; Padrini R
Clin Pharmacol Ther; 2002 Dec; 72(6):702-10. PubMed ID: 12496751
[TBL] [Abstract][Full Text] [Related]
6. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
Liao K; Liu Y; Ai CZ; Yu X; Li W
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Potential Association of Drug-Metabolizing Enzymes
Elfaki I; Mir R; Abu-Duhier FM; Jha CK; Ahmad Al-Alawy AI; Babakr AT; Habib SAE
Curr Drug Metab; 2020; 21(14):1152-1160. PubMed ID: 33115391
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.
Zhang J; Tian L; Huang J; Huang S; Chai T; Shen J
Cardiovasc Ther; 2017 Feb; 35(1):26-32. PubMed ID: 27661060
[TBL] [Abstract][Full Text] [Related]
9. CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study.
Eltalal S; El Ayouty M; El-Said A; Wahba Y
Acta Neurol Belg; 2021 Dec; 121(6):1623-1631. PubMed ID: 32683556
[TBL] [Abstract][Full Text] [Related]
10. Impact of gamma-glutamyl carboxylase gene polymorphisms on warfarin dose requirement: a systematic review and meta-analysis.
Sun Y; Wu Z; Li S; Qin X; Li T; Xie L; Deng Y; Chen J
Thromb Res; 2015 Apr; 135(4):739-47. PubMed ID: 25681132
[TBL] [Abstract][Full Text] [Related]
11. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.
Namazi S; Azarpira N; Hendijani F; Khorshid MB; Vessal G; Mehdipour AR
Clin Ther; 2010 Jun; 32(6):1050-60. PubMed ID: 20637959
[TBL] [Abstract][Full Text] [Related]
12. An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children.
Makowska M; Smolarz B; Bryś M; Forma E; Romanowicz H
Int J Neurosci; 2021 Dec; 131(12):1147-1154. PubMed ID: 32567426
[TBL] [Abstract][Full Text] [Related]
13. The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.
Lane S; Al-Zubiedi S; Hatch E; Matthews I; Jorgensen AL; Deloukas P; Daly AK; Park BK; Aarons L; Ogungbenro K; Kamali F; Hughes D; Pirmohamed M
Br J Clin Pharmacol; 2012 Jan; 73(1):66-76. PubMed ID: 21692828
[TBL] [Abstract][Full Text] [Related]
14. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Brandão LR; Ito S
Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
[TBL] [Abstract][Full Text] [Related]
15. CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy.
Chang M; Söderberg MM; Scordo MG; Tybring G; Dahl ML
Eur J Clin Pharmacol; 2015 Apr; 71(4):433-9. PubMed ID: 25652102
[TBL] [Abstract][Full Text] [Related]
16. Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.
Zhang J; Chen Z; Chen C
Meta Gene; 2016 Sep; 9():197-209. PubMed ID: 27617219
[TBL] [Abstract][Full Text] [Related]
17. Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
Ju S; Gao Y; Cao X; Zhang XF; Yan CC; Liu FT
Genet Test Mol Biomarkers; 2017 Sep; 21(9):539-546. PubMed ID: 28872889
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Biss T; Kamali F; Vear SI; Ho RH; Bajolle F; Loriot MA; Shaw K; Carleton BC; Hamberg AK; Wadelius M; Hirono K; Taguchi M; Wakamiya T; Yanagimachi M; Hirai K; Itoh K; Brandão LR; Ito S
Pharmacogenomics J; 2020 Apr; 20(2):306-319. PubMed ID: 31673144
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between CYP2C19 Gene Polymorphism and Elderly Cerebral Infarction].
Fan DJ; Li CY; Chen J; Ye ZQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):765-768. PubMed ID: 30606386
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
Yan Y; Hao R; Zhao X; Xia X; Wang L; Li X
J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106798. PubMed ID: 36215918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
